Back to search
FDAFDA · Food and drugs·Recall number Z-0572-2014

Captia Syphilis-G Test Kit Product Usage: This is an enzyme immunoassay for the qualitative detection of IgG antibodies to T. pallidum in serum specimens, to be used in conjunction with non-treponemal testing to provide serological evidence of infection with T. pallidum ( the agent of syphilis). It is also intended for testing of serum or plasma specimens to screen blood and/or plasma donors to exclude a history of syphilis.

Published January 1, 2014 · Recall initiated: August 27, 2013

Summary

FDA records medical device Class II recall Z-0572-2014, published January 1, 2014 and initiated August 27, 2013. Recalling firm: Clark Laboratories, Inc. (dba,Trinity Biotech USA); Status: Terminated; Reported quantity: 38 kits; Lot: Product Code: 800-960, Lot number: 082, Model: 10 - plate kit. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Trinity Biotech recalled Trinity Biotech Captia Syphilis IgG kits due to false negative results.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Clark Laboratories, Inc. (dba,Trinity Biotech USA)
Distributor
USA Nationwide Distribution in the state of WA
Lot
Product Code: 800-960, Lot number: 082, Model: 10 - plate kit
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Captia Syphilis-G Test Kit Product Usage: This is an enzyme immunoassay for the qualitative detection of IgG antibodies to T. pallidum in serum specimens, to be used in conjunction with non-treponemal testing to provide serological evidence of infection with T. pallidum ( the agent of syphilis). It is also intended for testing of serum or plasma specimens to screen blood and/or plasma donors to exclude a history of syphilis. recalled?

Yes. FDA published recall Z-0572-2014 on January 1, 2014. Reported hazard: Trinity Biotech recalled Trinity Biotech Captia Syphilis IgG kits due to false negative results.

What should I do if I have this product?

Voluntary: Firm initiated · Letter